Inventor

Ali Gure

Inventor
New York, NY, US

Overview

27→
Patents
1998–2013
Patent span
Chemistry
Primary field (CPC C)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides31%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C12NMicroorganisms or enzymes9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C07HSugars3%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
8,541,202'Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein'20138,142,786'Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein'20128,071,717'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof'20117,888,100'Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein'20117,795,409'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof'20107,622,568'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof'20097,354,992'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof'20087,335,467'Breast cancer antigens'20087,314,721'Small cell lung cancer associated antigens and uses therefor'20087,132,507'Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses'20067,115,729'Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53'20066,911,529'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof'20056,830,924'Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof'20046,774,226'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof'20046,723,832'Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof'20046,686,147'Cancer associated antigens and uses therefor'20046,576,756'Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof'20036,448,073'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof'20026,339,140'SSX family proteins'20026,297,364'Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof'20016,291,658'Isolated nucleic acid molecules encoding SSX family members and thereof'20016,287,756'Methods for determining presence of cancer in a sample by determining expression of an SSX gene'20016,274,145'Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof'20016,255,470'Isolated nucleic acid molecule encoding an esophageal cancer associated antigen'20016,069,233'Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof'20005,958,412'Methods of treating colon cancer utilizing tumor-specific antibodies'19995,804,381'Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2013Patents assigned to LUDWIG INST CANCER RES (24)· patent assignee history
1998–2011Patents assigned to CORNELL RES FOUNDATION INC (14)· patent assignee history
1998–2011Patents assigned to SLOAN KETTERING INST CANCER (14)· patent assignee history
1998–2013Based in New York, NY, US· patent location history
2009Based in NY, NY, US· patent location history
2011–2013Patents assigned to CHEN YAO-TSENG (3)· patent assignee history
2011–2013Patents assigned to GURE ALI (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LUDWIG INST CANCER RES241998–2013
CORNELL RES FOUNDATION INC141998–2011
SLOAN KETTERING INST CANCER141998–2011
CHEN YAO-TSENG32011–2013
GURE ALIself32011–2013
Locations
LocationPatentsSpan
New York, New York, US261998–2013
NY, New York, US12009